Form D · Biotechnology
Liminal BioSciences Inc.
Laval, A8 · CIK 0001351172
Offering snapshot reported Nov 18, 2020 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 3, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 18, 2020 | Initial | $29,999,436 | No comparison | 2 | SEC filing |
| Jun 24, 2019 | Initial | $37,140,000 | No comparison | 2 | SEC filing |
| Jan 8, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 16, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 17, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $1.8M
- Finders' fees
- $0
- Form D file number
- 021-380864
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Piper Sandler & Co. | 665 |
Source: Form D, filed Nov 18, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Simon G. Best | Director |
| Gary J. Bridger | Director |
| Stefan Victor Clulow | Director |
| Moira Daniels | Executive |
| Kenneth Galbraith | Director, Executive |
| Marie Iskra | Executive |
| Charles Kenworthy | Director |
| Neil A. Klompas | Director |
| Alek Krstajic | Director |
| Martin Leclerc | Executive |
| Murielle Lortie | Executive |
| Paul Mesburis | Director |
| John Moran | Executive |
| Zachary Newton | Director |
| Bruce Pritchard | Executive |
| Patrick Victor Santore | Executive |
| Patrick Sartore | Executive |
| Eugene Siklos | Director |
| Timothy Steven Wach | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
440 Armand Frappier Blvd. Suite 300
Laval, A8, H7V 4B4
Laval, A8, H7V 4B4